SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in developing clinically deep Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, ...

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...

Limitations from commercial software applications prevent the implementation of a robust and cost-efficient high-throughput cancer imaging radiomic feature extraction and perfusion analysis workflow.

Fig. 1. CBF and Tmax maps derived from the model and CTP showing three patients with different cores and low perfusion volumes in the test dataset and the corresponding maximum intensity projection ...

The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offisite pharmacy and delivered as a ready-to-use unit dose. The Food and Drug Administration (FDA) ...

Association Between Body Composition and Survival in Patients With Gastroesophageal Adenocarcinoma: An Automated Deep Learning Approach Limitations from commercial software applications prevent the ...

BARCELONA, Spain ― Artificial intelligence (AI) software substantially reduced false positives on myocardial perfusion imaging (MPI) for the diagnosis of coronary artery disease in high-risk patients, ...

Researchers from the Mayo Clinic have reported findings from the preclinical evaluation of a novel cardiac targeting peptide (CTP)-based radiotracer – [68Ga]NOTA-CTP – being developed as a myocardial ...

A cross-disciplinary research team has, for the first time, successfully applied NIR-II (1,000–3,000 nm) fluorescence video imaging during esophagectomy—a complex surgical procedure involving the ...

The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...